Long-acting antipsychotic drugs for the treatment of schizophrenia: use in daily practice from naturalistic observations
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Long-acting antipsychotic drugs for the treatment of schizophrenia: use in daily practice from naturalistic observations
Authors
Keywords
-
Journal
BMC Psychiatry
Volume 12, Issue 1, Pages -
Publisher
Springer Nature
Online
2012-08-21
DOI
10.1186/1471-244x-12-122
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Medication adherence and patient choice in mental health
- (2014) Kirsty Mackay et al. BRITISH JOURNAL OF HOSPITAL MEDICINE
- Is the PANSS used correctly? a systematic review
- (2011) Michael Obermeier et al. BMC Psychiatry
- The clinical global impression scale and the influence of patient or staff perspective on outcome
- (2011) Thomas Forkmann et al. BMC Psychiatry
- Individualizing antipsychotic treatment selection in schizophrenia: characteristics of empirically derived patient subgroups
- (2011) C.U. Correll et al. EUROPEAN PSYCHIATRY
- Long-term remission in schizophrenia and related psychoses with long-acting risperidone: Results obtained in an open-label study with an observation period of 18 months
- (2011) P.-M. Llorca et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Sex Differences in Use of Psychotropic Drugs and Drug-Induced Side Effects in Schizophrenia Patients: Findings of the Research on Asia Psychotropic Prescription (REAP) Studies
- (2010) Yu-Tao Xiang et al. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
- Treatment adherence in psychoses
- (2010) Anthony S. David BRITISH JOURNAL OF PSYCHIATRY
- Psychiatrists’ attitude to antipsychotic depot treatment in patients with first-episode schizophrenia
- (2010) S. Heres et al. EUROPEAN PSYCHIATRY
- Clinical guideline recommendations for antipsychotic long-acting injections
- (2009) John M. Kane et al. BRITISH JOURNAL OF PSYCHIATRY
- Long-Acting Injectable Risperidone in the Treatment of Subjects With Recent-Onset Psychosis
- (2009) Robin Emsley et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- The combined use of risperidone long-acting injection and clozapine in patients with schizophrenia non-adherent to clozapine: a case series
- (2009) Se Hyun Kim et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Psychiatrists’ use, knowledge and attitudes to first- and second-generation antipsychotic long-acting injections: comparisons over 5 years
- (2009) MX Patel et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Health literacy: A barrier to pharmacist–patient communication and medication adherence
- (2009) Lucy Nkukuma Ngoh JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION
- Attitudes towards long-acting depot antipsychotics: A survey of patients, relatives and psychiatrists
- (2009) Matthias Jaeger et al. PSYCHIATRY RESEARCH
- Connecting patient needs with treatment management
- (2008) R. Kerwin ACTA PSYCHIATRICA SCANDINAVICA
- Improved symptom control, functioning and satisfaction in French patients treated with long-acting injectable risperidone
- (2008) P.-M. Llorca et al. ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE
- L’alliance thérapeutique, un enjeu dans la schizophrénie
- (2008) A. Charpentier et al. ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE
- Remission in patients with first-episode schizophrenia receiving assured antipsychotic medication: a study with risperidone long-acting injection
- (2008) Robin Emsley et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Low doses of antipsychotic drugs for hospitalized schizophrenia patients in East Asia: 2004 vs. 2001
- (2008) Kang Sim et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Dosing patterns in Europe: Efficacy and safety of risperidone long-acting injectable in doses of 25, 37.5 and 50 mg
- (2008) Massimo Carlo Mauri et al. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
- Impact of risperidone long acting injection on resource utilization in psychiatric secondary care
- (2008) M. Taylor et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Cost-Utility Analysis of Treatment with Olanzapine Compared with Other Antipsychotic Treatments in Patients with Schizophrenia in the Pan-European SOHO Study
- (2008) Martin Knapp et al. PHARMACOECONOMICS
- Predictors of the course of illness in outpatients with schizophrenia: A prospective three year study
- (2008) J.M. Haro et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Identifying the profile of optimal candidates for antipsychotic depot therapy
- (2008) Stephan Heres et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Recovery in the outpatient setting: 36-month results from the Schizophrenia Outpatients Health Outcomes (SOHO) study
- (2008) Diego Novick et al. SCHIZOPHRENIA RESEARCH
- The Schizophrenia Outpatient Health Outcomes (SOHO) study: 3-year results of antipsychotic treatment discontinuation and related clinical factors in Spain
- (2007) Antonio Ciudad et al. EUROPEAN PSYCHIATRY
- Classifying Patients by Antipsychotic Adherence Patterns Using Latent Class Analysis: Characteristics of Nonadherent Groups in the California Medicaid (Medi-Cal) Program
- (2007) Jeonghoon Ahn et al. VALUE IN HEALTH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now